No Photo Available

Last Update

2016-10-05T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Morteza Naghavi?

Dr. Morteza Naghavi

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

President

MEDITEX Capital

President and Chief Executive Officer

CardioNexus Corporation

Affiliations

Founder
The Society for Heart Attack Prevention and Eradication

Founder
Endothelix Inc

Scientific Advisory Board Member
IC Therapeutics Inc

Founder, Board of Directors Member and Scientific Advisory Board Member
ThermaRx, Inc.

Founder
Red Circle

Founder
Association for Eradication of Heart Attack

Cardiology Faculty Member and Co-Director of the Vulnerable Plaque Research Department
University of Texas Health Science Center

Faculty Member
University of Texas

Founder
Invention-Innovation-Investment Ventures

Member of the Cardiology Faculty
theUniversity

Education

Tehran University

M.D.

MD

Tehran University of Medical Sciences

Web References (190 Total References)


Morteza Naghavi, ...

shapesociety.org [cached]

Morteza Naghavi, M.D. Founder and Executive Chairman of the SHAPE Task Force, President of MEDITEX

...
Morteza Naghavi, M.D. Executive Chairman of SHAPE Task Force
...
Morteza Naghavi, M.D.
...
Presenters: Robert Superko, M.D., Jessica Mega, M.D., Morteza Naghavi, M.D.
...
Morteza Naghavi, M.D.
...
David Maron, M.D. and Morteza Naghavi, M.D.
...
Morteza Naghavi, M.D.


AHA 2013 Unofficial Satellite Event - Invitation Only Scientific Focus Group Meeting

www.ictherapeutics.com [cached]

Morteza Naghavi, M.D.

Founder and President, Society for Heart Attack Prevention and Eradication (SHAPE) Chief Executive Officer, Meditex Capital, Inc., Houston, TX


Morteza Naghavi, ...

www.ictherapeutics.com [cached]

Morteza Naghavi, M.D. Dr. Naghavi is the founder and president of MEDITEX, a medical technology innovation and investment company dedicated to translating innovative ideas to healthcare solutions. He is also the Founder and Executive Chairman of the Society for Heart Attack Prevention and Eradication (SHAPE) based in Houston, Texas. Dr. Naghavi received his MD from Tehran University of Medical Sciences and was trained at the University of Texas Health Science Center in Houston and Texas Heart Institute where he served as a cardiology faculty member and Co-Director of the Vulnerable Plaque Research Department. Dr. Naghavi led advancing the field of "Vulnerable Plaque" to "Vulnerable Patient" and organized the SHAPE Task Force to focus on early detection and treatment of asymptomatic patients with subclinical atherosclerosis through the SHAPE Guidelines. He has over 30 inventions in the fields of interventional cardiology, noninvasive imaging, ambulatory diagnostics, wearable sensors, and personalized preventive healthcare. Among his inventions are digital thermal monitoring of vascular function and personalized ischemic conditioning device. Dr. Naghavi has numerous publications and is the editor of Asymptomatic Atherosclerosis; Pathophysiology,Detection and Treatment.


Dr. Naghavi is an innovative ...

shapesociety.org [cached]

Dr. Naghavi is an innovative physician, inventor, researcher, entrepreneur, and venture capitalist with interests in preventive cardiology, medical technology, and digital health. He graduated as a M.D. from Tehran University and was trained as a cardiovascular physician scientist under distinguished cardiologists Late Dr. Ward Casscells and Dr. James T. Willerson at the Texas Heart Institute and the University of Texas Health Science Center in Houston. Dr. Naghavi has also greatly benefited from mentorship of Dr. Valentin Fuster, the world renowned cardiologist of Mount Sinai Medical Center in New York, and Dr. P.K. Shah, the distinguished physician scientist in atherosclerosis and professor of medicine at UCLA.

...
Dr. Naghavi is internationally recognized as a leader in heart attack prevention initiatives focusing on the detection of individuals with high risk asymptomatic atherosclerotic namely Vulnerable Plaques and Vulnerable Patients. Pursuant to his research in the field of Vulnerable Plaque, along with Drs Shah, Falk and others, Dr. Naghavi founded the Society for Heart Attack Prevention and Eradication (SHAPE) and is the Executive Chairman of the SHAPE Task Force.
...
In 2006, with tireless efforts of Dr. Naghavi and colleagues at the SHAPE Task Force, the SHAPE Guidelines were published in American Journal of Cardiology and created a huge wave of awareness by calling on physicians to go beyond traditional risk factors of atherosclerosis (e.g. high cholesterol and blood pressure), and focus on the detection of atherosclerosis itself. The SHAPE Guidelines recommend noninvasive detection of atherosclerosis by cardiac CT scan and carotid ultrasound scan. Over years the SHAPE initiative has increasingly gained recognition, however unfortunately, due to the lack of insurance reimbursement for such preventive screening, most physicians are unable to practice the SHAPE Guidelines. In 2009, the SHAPE organization led by Dr. Naghavi helped pass Texas legislation HB1290 which became the first heart attack preventive screening law in the United States. Other states such as Florida, Maryland, Rode Island and California are following the Texas SHAPE initiative. In addition to SHAPE, Dr. Naghavi has a number of collaborative academic research initiatives including NIH and NSF funded projects. He has numerous scientific publications in medical journals, most notably three major publications (From Vulnerable Plaque to Vulnerable Patient, A Call for New Definitions and Risk Assessment Strategies:Part I , Part II, and Part III, the HAPE Guidelines. Dr. Naghavi is the editor of "Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment", the most comprehensive scientific collection on risk assessment of the Asymptomatic Vulnerable Patient. Along with academic activities, Dr. Naghavi is also an inventor and entrepreneur with over 30 patents and 5 medical. One of his companies Endothelix Inc www.endothelix.com was awarded $1,000,000 from State of Texas as a top emerging medical technology in Texas. He is currently the President of MEDITEX. Dr. Naghavi and colleagues are passionate about transforming new ideas into healthcare solutions that prolong life and enhance the quality of life.
...
Editor: Morteza Naghavi, M.D., Co-Editors: Mathew Budoff, M.D., Daniel Berman M.D., Erling Falk, M.D., Ph.D., Zahi Fayad, M.D., Harvey Hecht, M.D., Khurram Nasir, M.D., Prediman K. Shah, M.D.


Update on Clinical Applications of Ischemic Conditioning 2014 - Chicago, IL

www.ictherapeutics.com [cached]

Morteza Naghavi, M.D. Founder and President, Society for Heart Attack Prevention and Eradication (SHAPE) Chief Executive Officer, MEDITEX Capital, Houston, TX

...
Robert A. Kloner, M.D., Ph.D. and Morteza Naghavi, M.D.

Similar Profiles

Other People with this Name

Other people with the name Naghavi

Fred Naghavi
Purdue Pharma

Faranak Naghavi
Ernst & Young LLP

Nima Naghavi
York Region Transit

Eman Naghavi
McNeese Sports YouTube

Yasmin Naghavi
Media Arts Lawyers

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory